These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 36757444)
1. Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor? Wu PH; Huo WX; Mo XD; Wang Y; Yan CH; Jiang H; Shen MZ; Huang XJ; An YZ Ann Hematol; 2023 Apr; 102(4):907-916. PubMed ID: 36757444 [TBL] [Abstract][Full Text] [Related]
3. Sequential Organ Failure Assessment Score and the Need for Organ Support Predict Mortality in Allogeneic Stem Cell Transplant Patients Admitted to the Intensive Care Unit. Díaz-Lagares C; Fox L; García-Roche A; Santafe M; Romera I; Barba P; Pacheco A; Roldán E; Plata-Menchaca E; Roca O; Pérez M; Valcarcel D; Ferrer R Transplant Cell Ther; 2021 Oct; 27(10):865.e1-865.e7. PubMed ID: 34217846 [TBL] [Abstract][Full Text] [Related]
4. Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Saillard C; Blaise D; Mokart D Bone Marrow Transplant; 2016 Aug; 51(8):1050-61. PubMed ID: 27042832 [TBL] [Abstract][Full Text] [Related]
5. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411 [TBL] [Abstract][Full Text] [Related]
6. Mortality of Oncohematological Patients Undergoing Hematopoietic Stem Cell Transplantation Admitted to the Intensive Care Unit. Corcía Palomo Y; Knight Asorey T; Espigado I; Martín Villén L; Garnacho Montero J Transplant Proc; 2015 Nov; 47(9):2665-6. PubMed ID: 26680067 [TBL] [Abstract][Full Text] [Related]
7. Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients. Solaiman OM; Elhassan T; Fakih RE; Mannan A; Alduhailib Z; Mahdali AA; Alzahrani H; Jamil M; Chaudhri N; Elhazmi A; Kolko M; Al-Sharif FZ; Alrbiaan A; Shaban M; Shaheen M; Salahuddin N; Alfraih FA; Altarifi AS; Hassanein M; Hosaini S; Alhashim N; Mohamed AA; Hanbali A; Aljanoubi AH; Al-Obaidi NR; Rasheed W; Maghrabi K; Almohareb F; Soubani A; Aljurf M; Ahmed SO Hematol Oncol Stem Cell Ther; 2024 Mar; 17(2):110-119. PubMed ID: 38560973 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU). Serries M; Zenzen H; Heine M; Holderried T; Brossart P; Schwab K Hematology; 2023 Dec; 28(1):2256198. PubMed ID: 37737158 [TBL] [Abstract][Full Text] [Related]
9. One-year mortality of hematopoietic stem cell recipients admitted to an intensive care unit in a dedicated Brazilian cancer center: a retrospective cohort study. Archanjo LVF; Caruso P; Nassar Junior AP Sao Paulo Med J; 2022; 141(2):107-113. PubMed ID: 35920534 [TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation. Wang Y; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Wei F; Han W; Wang F; Wang J; Huang X; Mo X Virol J; 2024 May; 21(1):110. PubMed ID: 38745209 [TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit. Mokart D; Granata A; Crocchiolo R; Sannini A; Chow-Chine L; Brun JP; Bisbal M; Faucher M; Faucher C; Blache JL; Castagna L; Fürst S; Blaise D J Crit Care; 2015 Oct; 30(5):1107-13. PubMed ID: 26193780 [TBL] [Abstract][Full Text] [Related]
12. Outcomes in Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients. Lafarge A; Dupont T; Canet E; Moreau AS; Picard M; Mokart D; Platon L; Mayaux J; Wallet F; Issa N; Raphalen JH; Pène F; Renault A; Peffault de la Tour R; Récher C; Chevallier P; Zafrani L; Darmon M; Bigé N; Azoulay E Am J Respir Crit Care Med; 2024 Oct; 210(8):1017-1024. PubMed ID: 39018219 [No Abstract] [Full Text] [Related]
13. Feasibility of Cyclosporine Prophylaxis Withdrawal in Critically Ill Allogenic Hematopoietic Stem Cell Transplant Patients Admitted to the Intensive Care Unit With No GVHD. Saillard C; Legal PH; Furst S; Bisbal M; Servan L; Sannini A; Gonzalez F; Faucher M; Vey N; Blaise D; Chow-Chine L; Mokart D Transplant Cell Ther; 2022 Nov; 28(11):783.e1-783.e10. PubMed ID: 35964937 [TBL] [Abstract][Full Text] [Related]
14. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study. Barlas T; İnci K; Aygencel G; Türkoğlu M; Tunçcan ÖG; Can F; Aydın Kaynar L; Özkurt ZN; Yeğin ZA; Yağcı M Hematology; 2021 Dec; 26(1):328-339. PubMed ID: 33818297 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for ICU mortality in patients with hematological malignancies: a singlecenter, retrospective cohort study from Turkey. Bıkmaz ŞGA; Gökçe O; Haşimoğlu MM; Boyacı N; Türkoğlu M; Yeğin ZA; Özkurt ZN; Yağcı AM Turk J Med Sci; 2023 Feb; 53(1):340-351. PubMed ID: 36945922 [TBL] [Abstract][Full Text] [Related]
16. Characteristics and outcomes of autologous hematopoietic stem cell transplant recipients admitted to intensive care units: A multicenter study. Nassar AP; Archanjo LVF; Ranzani OT; Zampieri FG; Salluh JIF; Cavalcanti GFR; Moreira CEN; Viana WN; Costa R; Melo UO; Roderjan CN; Correa TD; de Almeida SLS; Azevedo LCP; Maia MO; Cravo VS; Bozza FA; Caruso P; Soares M J Crit Care; 2022 Oct; 71():154077. PubMed ID: 35636348 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. Yeo CD; Kim JW; Kim SC; Kim YK; Kim KH; Kim HJ; Lee S; Rhee CK J Crit Care; 2012 Dec; 27(6):739.e1-6. PubMed ID: 23217573 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study. Azoulay E; Mokart D; Pène F; Lambert J; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Laisne LM; Rabbat A; Lebert C; Perez P; Chaize M; Renault A; Meert AP; Benoit D; Hamidfar R; Jourdain M; Darmon M; Schlemmer B; Chevret S; Lemiale V J Clin Oncol; 2013 Aug; 31(22):2810-8. PubMed ID: 23752112 [TBL] [Abstract][Full Text] [Related]
19. Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation. Kaito S; Wada A; Adachi H; Konuma R; Kishida Y; Nagata A; Konishi T; Yamada Y; Kumagai T; Yoshifuji K; Mukae J; Akiyama M; Inamoto K; Toya T; Igarashi A; Najima Y; Muto H; Kobayashi T; Kakihana K; Ohashi K; Sakamaki H; Doki N Ann Hematol; 2020 Jul; 99(7):1655-1665. PubMed ID: 32524200 [TBL] [Abstract][Full Text] [Related]
20. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates. Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]